ArticleInternational journal of clinical oncology2021

Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting.

Manglio Miguel Rizzo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.